{
  "id": 10976855,
  "title": "AbbVie's eczema drug shows benefit in Phase 2; BioMarin lays off 117",
  "url": "https://urgent.news/2026/09/30/abbvies-eczema-drug-shows-benefit-in-phase-2-biomarin-lays-off-117",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-30T15:32:50.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/abbvies-eczema-drug-shows-benefit-in-phase-2-biomarin-lays-off-117/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Sarepta, Rafael Holdings, Sagimet, Pyxis Oncology, Connect Biopharma, Asahi Kasei, Astrocyte Pharmaceuticals, GSK, Wave and Kailera. AbbVie unveils Phase 2 data for Apogee drug: Zumilokibart, an anti-IL-13 antibody, produced statistically significant benefits ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}